0001486430-14-000004.txt : 20140501 0001486430-14-000004.hdr.sgml : 20140501 20140501180436 ACCESSION NUMBER: 0001486430-14-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140430 FILED AS OF DATE: 20140501 DATE AS OF CHANGE: 20140501 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PERNIX THERAPEUTICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001024126 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330724736 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 884 JOHNNIE DODDS BLVD STREET 2: SUITE 201 CITY: MOUNT PLEASANT STATE: SC ZIP: 29464 BUSINESS PHONE: (832) 934-1825 MAIL ADDRESS: STREET 1: 884 JOHNNIE DODDS BLVD STREET 2: SUITE 201 CITY: MOUNT PLEASANT STATE: SC ZIP: 29464 FORMER COMPANY: FORMER CONFORMED NAME: GOLF TRUST OF AMERICA INC DATE OF NAME CHANGE: 19961002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith James Edward Jr. CENTRAL INDEX KEY: 0001486430 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14494 FILM NUMBER: 14806319 MAIL ADDRESS: STREET 1: 33219 FOREST WEST DRIVE CITY: MAGNOLIA STATE: TX ZIP: 77354 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2014-04-30 0 0001024126 PERNIX THERAPEUTICS HOLDINGS, INC. PTX 0001486430 Smith James Edward Jr. 700 CAMP STREET NEW ORLEANS LA 70130 0 0 1 0 Common Stock 2014-04-30 4 S 0 15000 4.7193 D 4397704 D Common Stock 2014-05-01 4 S 0 15000 4.6324 D 4382704 D Common Stock 3200 I By Daughter The sales reported in the Form 4 were effected pursuant to Rule 144. The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.59 to $4.81, inclusive. The reporting person will provide Pernix Therapeutics Holdings, Inc, any security holder of Pernix Therapeutics Holdings, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.53 to $4.79, inclusive. The reporting person will provide Pernix Therapeutics Holdings, Inc, any security holder of Pernix Therapeutics Holdings, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Smith James Edward Jr 2014-05-01